Electrophysiological characterisation and monitoring in the management of birdshot chorioretinopathy

British Journal of Ophthalmology

Volumn 89, Issue 6, 2005, Pages 709-718

  Holder, G E ^a   Robson, A G ^a   Pavesio, C ^a   Graham, E M ^b  

^a MOORFIELDS EYE HOSPITAL   (United Kingdom)

^b ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN; HLA A ANTIGEN; HLA A29 ANTIGEN; PREDNISOLONE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CHORIORETINOPATHY; CLINICAL ARTICLE; CLINICAL FEATURE; ELECTROPHYSIOLOGY; ELECTRORETINOGRAM; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; PRIORITY JOURNAL; RETINA; RETINA CONE; RETINA DISEASE; RETINA MACULA EDEMA; RETINA MACULA LUTEA; RETINA ROD; VITILIGINOUS CHORIORETINITIS;

ADULT; CHORIORETINITIS; DRUG MONITORING; DRUG THERAPY, COMBINATION; ELECTROOCULOGRAPHY; ELECTRORETINOGRAPHY; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; GLUCOCORTICOIDS; HLA-A ANTIGENS; HUMANS; HYPOPIGMENTATION; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PREDNISOLONE; RETINA; TREATMENT OUTCOME; VISION DISORDERS; VISUAL ACUITY;

EID: 20344363648     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2004.047837     Document Type: Article

References (31)

1. Ryan SJ, Maumenee AE. Birdshot retinochoroidopathy. Am J Ophthalmol 1980;89:31-45.
2. Kaplan HJ, Aaberg TM. Birdshot retinochoroidopathy. Am J Ophthalmol 1980;90:773-82.
3. Priem HA, Oosterhuis JA. Birdshot chorioretinopathy: clinical characteristics and evolution. Br J Ophthalmol 1988;72:646-59.
4. Rothova A, Van Schooneveld MJ. The end stage of birdshot retinochoroidopathy. Br J Ophthalmol 1995;79:1058-9.
5. Nussenblatt RB, Mittal KK, Ryan S, et al. Birdshot retinochoroidopathy associated with HLA-A29 antigen and immune responsiveness to retinal S-antigen. Am J Ophthalmol 1982;94:147-58.
6. Fuerst DJ, Tessler HH, Fishman GA, et al. Birdshot retinochoroidopathy. Arch Ophthalmol 1984;102:214-19.
7. Baarsma GS, Kijlstra A, Oosterhuis JA, et al. Association of birdshot retinochoroidopathy and HLA-A29 antigen. Doc Ophthalmol 1986;61:267-9.
8. Baarsma GS, Priem HA, Kijlstra A. Association of birdshot retinochoroidopathy and HLA-A29 antigen. Curr Eye Res 1990;9(Suppl):63-8.
9. Priem HA, Kijlstra A, Noens L, et al. HLA typing in birdshot chorioretinopathy. Am J Ophthalmol 1988;105:182-5.
10. Gaudio PA, Kaye DB, Crawford J. Histopathology of birdshot chorioretinopathy. Br J Ophthalmol 2002;86:439-63.
11. Szpak Y, Vieville JC, Tabary T, et al. Spontaneous retinopathy in HLA-A29 transgenic mice. Proc Natl Acad Sci 2001;98:2572-6.
12. de Courten C, Herbort CP. Potential role of computerized visual field testing for the appraisal and follow-up of birdshot chorioretinopathy. Arch Ophthalmol 1998;116:1389-91.
13. Oh KT, Christmas NJ, Folk JC. Birdshot retinochoroiditis: long term follow-up of a chronically progressive disease. Am J Ophthalmol 2002;133:622-9.
14. Priem HA, De Rouck A, De Laey JJ, et al. Electrophysiologic studies in birdshot chorioretinopathy. Am J Ophthalmol 1988;106:430-6.
15. Hirose T, Katsumi O, Pruett RC, et al. Retinal function in birdshot retinochoroidopathy. Acta Ophthalmol 1991;69:327-37.
16. Marmor MF, Holder GE, Seeliger MW, et al. Standard for clinical electroretinography (2004 update). Doc Ophthalmol 2004;108:107-14.
17. Bach M, Hawlina M, Holder GE, et al. Standard for pattern electroretinography. Doc Ophthalmol 2000;101:11-18.
18. Marmor MF, Zrenner E. Standard for clinical electro-oculography. International Society for Clinical Electrophysiology of Vision. Doc Ophthalmol 1993;85:115-24.
19. Downes SM, Holder GE, Fitzke FW, et al. Autosomal dominant cone and cone-rod dystrophy with mutations in the guanylate cyclase activator 1A gene-encoding guanylate cyclase activating protein-1. Arch Ophthalmol 2001;119:96-105.
20. Calcagni A, Hogg CR, Spackman L, et al. Characterisation of the normal photopic electroretinographic responses to long duration stimuli evoked by a light emitting diode stimulator. Clin Neurophysiol 2001;112:1964-66.
21. Arden GB, Gunduz K, Perry S. Colour vision testing with a computer graphics system. Clin Vis Sci 1988;2:303-20.
22. Zacks DN, Samson CM, Loewenstein J, et al. Electroretinograms as an indicator of disease activity in birdshot retinochoroidopathy. Graefes Arch Clin Exp Ophthalmol 2002;240:601-7.
23. Holder GE. Pattern ERG and an integrated approach to visual pathway diagnosis. Prog Retin Eye Res 2001;20:531-61.
24. Bush RA, Sieving PA. Inner retinal contributions to the primate photopic fast flicker electroretinogram. J Opt Soc Am A 1996;13:557-65.
25. Alexander KR, Fishman GA, Peachey NS, et al. ON response defect in paraneoplastic night blindness with cutaneous malignant melanoma. Invest Ophthalmol Vis Sci 1992;33:477-83.
26. Lei B, Bush RA, Milam AH, et al. Human melanoma associated retinopathy (MAR) antibodies alter the retinal ON-response of the monkey ERG in vivo. Invest Ophthalmol Vis Sci 2000;41:262-6.
27. Koh AH, Hogg CR, Holder GE. The incidence of negative ERG in clinical practice. Doc Ophthalmol 2001;102:19-30.
28. Karpe G, Uchermann A. The clinical electroretinogram IV. The electroretinogram in circulatory disturbances of the retina. Acta Ophthalmol 1955;33:493-516.
29. Yotsukura J, Adachi-Usami E. Correlation of electroretinographic changes with visual prognosis in central retinal artery occlusion. Ophthalmologica 1993;207:13-18.
30. Dowling JE, Ripps H. Adaptation in skate photoreceptors. J Gen Physiol 1972;60:698-719.
31. Hood DC, Birch DG. Rod phototransduction in retinitis pigmentosa: estimation and interpretation of parameters derived from the rod a-wave. Invest Ophthalmol Vis Sci 1994;35:2948-61.